摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-cyano-1-(1H-indol-3-ylmethyl)-ethyl]-5-quinolin-6-yl-2-trifluoromethoxybenzamide | 1108612-88-9

中文名称
——
中文别名
——
英文名称
N-[2-cyano-1-(1H-indol-3-ylmethyl)-ethyl]-5-quinolin-6-yl-2-trifluoromethoxybenzamide
英文别名
N-[1-cyano-3-(1H-indol-3-yl)propan-2-yl]-5-quinolin-6-yl-2-(trifluoromethoxy)benzamide
N-[2-cyano-1-(1H-indol-3-ylmethyl)-ethyl]-5-quinolin-6-yl-2-trifluoromethoxybenzamide化学式
CAS
1108612-88-9
化学式
C29H21F3N4O2
mdl
——
分子量
514.507
InChiKey
BTKMXFPEEDCOOU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    38
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    90.8
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • Cyanomethyl substituted N-Acyl Tryptamines
    申请人:Bayer Schering Pharma Aktiengesellschaft
    公开号:EP2020404A1
    公开(公告)日:2009-02-04
    The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I in which R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
    本发明涉及具有以下结构的甲基取代的N-酰基色胺化合物,其中R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。根据本发明的化合物是有效的FSH拮抗剂,可用于男性或女性的生育控制,或用于骨质疏松症的预防和/或治疗。
  • CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES
    申请人:WORTMANN Lars
    公开号:US20090069321A1
    公开(公告)日:2009-03-12
    The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I in which R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
    本发明涉及公式I中的甲基取代N-酰基色胺类化合物,其中R1、R2、R3、R4、R5、Q、X和W的含义如描述中所定义。本发明的化合物是有效的FSH拮抗剂,例如可以用于男性或女性的生育控制,或用于骨质疏松的预防和/或治疗。
  • (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES
    申请人:Actelion Pharmaceuticals Ltd.
    公开号:EP2051962A1
    公开(公告)日:2009-04-29
  • [EN] (3-AMINO-1,2,3,4-TETRAHYDRO-9H-CARBAZOL-9-YL)-ACETIC ACID DERIVATIVES<br/>[FR] DÉRIVÉS DE L'ACIDE (3-AMINO-1,2,3,4-TÉTRAHYDRO-9H-CARBAZOL-9-YL)-ACÉTIQUE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2008017989A1
    公开(公告)日:2008-02-14
    [EN] The present invention relates to (3-amino-l,2,3,4-tetrahydro-9H-carbazol-9-yl)-acetic acid derivatives of Formula (I) wherein R1, R2, R3, R4, R5 and R6 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.
    [FR] La présente invention concerne des dérivés de l'acide (3-amino-1,2,3,4-tétrahydro-9H-carbazol-9-yl)-acétique de la Formule I (I) dans laquelle R1, R2, R3, R4, R5 et R6 sont tels que définis dans la description, et leur utilisation en tant que modulateurs des récepteurs de la prostaglandine, plus particulièrement comme modulateurs des récepteurs de la prostaglandine D2, dans le traitement de diverses maladies et troubles à médiation par la prostaglandine. La présente invention concerne également des compositions pharmaceutiques contenant ces composés et des procédés permettant de les préparer.
  • [EN] CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES<br/>[FR] N-ACYLTRYPTAMINES À SUBSTITUTION CYANOMÉTHYLE
    申请人:BAYER SCHERING PHARMA AG
    公开号:WO2009016253A2
    公开(公告)日:2009-02-05
    The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula (I) in which R1, R2, R3, R4, R5, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
查看更多